'How the Defend Trade Secrets Act Could Better Protect Manufacturers Who Outsource to CMOs,' Q&A with Maia Harris
BioPharm International spoke to Maia Harris, partner in Pepper Hamilton's IP Litigation Practice Group, to learn about how trade secrets protect the manufacture of biologic drugs and specifically how President Obama's signing of the Defend Trade Secrets Act (DTSA) into law might affect the protection of trade secrets at biomanufacturing firms.
Content contributed by attorneys of Troutman Sanders LLP and Pepper Hamilton LLP prior to April 1, 2020, is included here, together with content contributed by attorneys of Troutman Pepper (the combined entity) after the merger date.